Bodiongan, Shiela .
HRN: 18-65-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
CEFUROXIME 500MG (TAB)
01/17/2023
01/24/2023
ORAL
500mg
BID
S/P LTCS MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes